Ramucirumab: the long and winding road toward being an option for mCRC treatment-Reference-Cited by-同舟云学术

Ramucirumab: the long and winding road toward being an option for mCRC treatment

Published:2019-04-16 Issue:5 Volume:19 Page:399-409
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Debeuckelaere Celine¹,Murgioni Sabina²,Lonardi Sara²,Girardi Noemi³,Alberti Giulia²³,Fano Carolina⁴,Gallimberti Sara⁴,Magro Cristina⁴,Ahcene-Djaballah Selma²,Daniel Francesca²⁵,Fassan Matteo⁶,Prenen Hans¹⁷,Loupakis Fotios²

Affiliation:

1. Department of Oncology, University Hospital Antwerp, Edegem, Belgium

2. Department of Oncology, Unit of Oncology 1, Veneto Institute of Oncology, Scientific Institute for Research and Healthcare (IRCCS), Padua, Italy

3. Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy

4. Research Nurses Coordinating Center, Unit of Oncology 1, Veneto Institute of Oncology, Scientific Institute for Research and Healthcare (IRCCS), Padua, Italy

5. Clinical Oncology, Department of Morphology, Surgery and Experimental Medicine, S. Anna University Hospital, Ferrara, Italy

6. Department of Medicine, Pathology and Cytopathology Unit, Padua University Hospital, Padua, Italy

7. Center for Oncological Research, Antwerp University, Edegem, Belgium

Funder

Regione Veneto

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2019.1600505

Reference91 articles.